Informed choice of pregnant women in prenatal screening tests for Down's syndrome.

نویسندگان

  • H-H Chiang
  • Y-M Yu Chao
  • Y-S Yuh
چکیده

BACKGROUND Although maternal serum screening (MSS) for Down's syndrome has become routinely available in most obstetric clinics in many countries, few studies have addressed the reasons why women agree to undergo the MSS test. OBJECTIVES The aims of this study were to describe the circumstances in which MSS was offered to pregnant women and their reasons for undertaking it. METHODS Participant observation and in depth interviews were used in this study; specifically, the experiences of women who had a positive result for MSS and who then followed this up with amniocentesis were examined. The interviewees were twenty six mothers aged between 22 and 35 years. The interviews were audio taped and transcribed for analysis. The results were analysed by the constant comparative method. RESULTS This study identified the reasons on which pregnant women appeared to base their decisions when undergoing MSS. The reasons were first, the recognition that the procedure was a prenatal routine procedure; second, the need to avoid the risk of giving birth to a baby with Down's syndrome, and third, a trust in modern technology and in the professional authorities. CONCLUSIONS This study offers insights into the informed choice made by women with a positive MSS result. The reasons for undergoing MSS might help health professionals and policy makers to reflect on their practice and this may, in turn, improve the quality of prenatal care during MSS.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Relationship of Informed Choice about Fetal Anomaly Screening with Worry and Anxiety in Pregnant Women

Background & aim: The purpose of prenatal screening programs during pregnancy is to empower the women to make an informed choice and reduce the uncertainty in decision making. However, the screening itself may cause worry and anxiety in the pregnant females. This study aimed to investigate the relationship of the informed choice in the pregnant females about fetal anomaly screening with worry a...

متن کامل

Ethnic differences in informed decision-making about prenatal screening for Down's syndrome.

BACKGROUND The aim of this study was to assess ethnic variations in informed decision-making about prenatal screening for Down's syndrome and to examine the contribution of background and decision-making variables. METHODS Pregnant women of Dutch, Turkish and Surinamese origin were recruited between 2006 and 2008 from community midwifery or obstetrical practices in The Netherlands. Each woman...

متن کامل

Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down’s syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units

OBJECTIVE  To investigate the benefits and costs of implementing non-invasive prenatal testing (NIPT) for Down's syndrome into the NHS maternity care pathway. DESIGN  Prospective cohort study. SETTING  Eight maternity units across the United Kingdom between 1 November 2013 and 28 February 2015. PARTICIPANTS  All pregnant women with a current Down's syndrome risk on screening of at least 1...

متن کامل

Will the introduction of non-invasive prenatal diagnostic testing erode informed choices? An experimental study of health care professionals.

OBJECTIVE Informed choice is a fundamental concept within prenatal care. The present study assessed the extent to which the introduction of non-invasive prenatal diagnosis (NIPD) of Down's syndrome may undermine the process of making informed choices to undergo prenatal testing or screening for Down's syndrome by altering the quality and quantity of pre-test counselling. METHODS 231 obstetric...

متن کامل

Dennis Lo (1963- )

Dennis Lo, also called Yuk Ming Dennis Lo, is a professor at the Chinese University of Hong Kong [5] in Hong Kong, China. In 1997, Lo discovered fetal DNA in maternal plasma, which is the liquid component of a pregnant woman's blood. By 2002, Lo distinguished the DNA differences between pregnant women and their fetuses, enabling scientists to identify fetal DNA in pregnant women's blood. Lo use...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Journal of medical ethics

دوره 32 5  شماره 

صفحات  -

تاریخ انتشار 2006